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Resumo
Desde	 o	 final	 dos	 anos	 1960,	 há	 tentativas	
de	 produção	 de	 um	 contraceptivo	masculino	
reversível	 com	eficácia	 equivalente	 à	 da	 pílula	
anticoncepcional.	 Até	 hoje,	 esse	 produto	 não	
foi	 lançado,	e	as	 justificativas	para	 tal	baseiam-
se	 em	 entraves	 de	 ordem	política,	 econômica,	
cultural	 e	 biológica.	O	argumento	do	obstáculo	
fisiológico	 tem	bastante	 proeminência	 nessas	
explicações	e	será	o	nosso	foco	neste	artigo.	Com	
base	nos	estudos	de	gênero	e	 ciência,	buscamos	
compreender	 como	 esse	 raciocínio	 aparece	 no	
trabalho	 de	 viabilização	 dessa	 tecnologia	 por	
um	ator	 de	 destaque	no	 campo,	 a	 organização	
não	 governamental	 (ONG)	 estadunidense	Male	
Contraception	Initiative.	Por	meio	da	técnica	de	
análise	de	documentos	e	com	base	na	metodologia	
de	 análise	do	discurso,	 buscamos	 compreender	
como	 o	 corpo	 masculino	 é	 representado	 e,	
consequentemente,	materializado	nesse	processo	






























demands	 a	 very	 strict	 treatment,	with	many	
unwanted	side	effects.	(Por	que…,	2015)




Money	 is	 often	 the	guiding	word	 for	 decision	
making	 in	all	 industries.	The	cost	of	developing	
new	drugs	reaches	hundreds	of	millions	of	dollars,	
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some	device,	 similar	 to	 the	 idea	of	 a	 reversible	
vasectomy.
Based	 on	gender	 and	 science	 studies,	male	
contraceptives	 in	 development	 interest	 us	 as	








our	 attention.	The	discourses	 and	practices	 of	
the	actors	 involved	directly	or	 indirectly	 in	 their	
development	 involve	 the	 relationships	between	
men	and	women,	 their	bodies	and	 the	meanings	

























of	non-hormonal	 contraceptive	 technologies.	 In	
addition	to	engaging	in	the	production	of	certain	




importance	 and	need,	 developing	 actions	 and	
promotional	materials.	MCI	is	one	of	five	institutions	
composing	 the	 International	 Consortium	 for	













videos,	 a	method	 that	 seeks	 to	understand	 the	









relation	 to	 the	 reproduction	of	 social	 relations,	
ideologies	and	hegemonies	(Lupton,	1992).





because	 they	 are	 the	NGO’s	main	medium	 for	
presenting	 its	 arguments	and	debates	on	male	
contraception.	MCI’s	Facebook	page	was	created	















The physiological-dif f icul ty 
justification in the field of male 
contraception
The	 supposed	 existence	 of	 a	 physiological	
impediment	 to	masculine	 contraception	 is	not	
something	new	 in	 the	field.	Nelly	Oudshoorn	 in	
her	 biography	 of	 the	 “male	 pill”	 (2003),	which	
encompasses	 several	 attempts	 to	 develop	 this	
technology	between	 the	 late	 1960s	and	 the	 late	
1990s,	points	out	that	the	difficulty	of	suppressing	
sperm	production	in	a	reversible	manner	and	the	

































in	 the	 case	of	women’s	bodies,	 such	effects	did	
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not	men.	(Jornal	de	Santa	Catarina,	1978,	page	5,	
cited	by	Silva,	2004,	p.161)
Several 	 projects	 aimed	 at 	 developing	
contraceptives	 for	men,	 especially	 hormonal	
contraceptives,	were	 suspended	because	of	 the	
































































MCI	 also	 emphasizes	 the	 omission	 of	 the	




financial	 risk,	 complex	 regulations	 and	many	
years	 of	work,	 as	well	 as	high	 risk	 of	 lawsuits	
related	 to	 safety	 and	 efficacy,	 and	 is	 thus	not	
attractive	 to	 large	 pharmaceutical	 companies.	
In	the	case	of	technologies	for	men,	the	rejection	
of	 the	 industry	 is	 even	 greater,	 due	 to	 doubts	
regarding	consumer	interest.









Finding	 a	male	 birth	 control	 option	 besides	
vasectomies	and	condoms	has	proved	difficult	
because	 men	 are	 capable	 of	 producing	 an	
astounding	1,500	sperm	cells	in	a	single	second.	
(Schubert,	2016)
The	 biology	 is	 the	 biggest	 hurdle	…	 at	 every	
heartbeat	men	 produce	 thousands	 of	 sperm	
(Senthilingam,	2016).
MCI	 does	 not	 deny	 this,	 but	 presents	 the	
physiological	impediment	as	a	problem	specifically	
related	to	hormonal	approaches.	In	a	video	–	“Why 




it	 is	possible	 to	prevent	contraception	 in	women	
with	 low	doses,	whereas	 for	men	 it	would	 take	
high	hormonal	doses,	producing	many	side	effects	






















































Based	on	 these	 criticisms,	MCI	advocates	 a	
change	 in	 the	 field	 of	male	 contraceptives,	 so	
investments	and	efforts	will	focus	on	non-hormonal	





We	 could	 be	wrong,	 but	we	would	 feel	much	
better	 if	other	approaches	 for	developing	male	
contraceptives were	getting	as	much	attention	
and	 funding	as	male	hormonal	methods	 –	 even	
though	there	are	more	unknowns	for	non-hormonal	




































































of	 these	manuals,	 through	 figures	 and	 texts,	
presents	 the	hormones	 considered	 feminine	as	
weaker	 and	 less	 objective	 than	 the	masculine,	
besides	emphasizing	 their	 role	 in	 reproduction.	
He	also	analyzes	figures	comparing	the	functions	
of	testosterone	with	those	of	estradiol,	concluding	









act	by	 facilitating	 the	maintenance	of	 erection,	
materializing	 a	male	 sexuality	 focused	on	 the	
penis.	Mainly	due	to	the	success	and	diffusion	of	












while	 the	 female	body	 is	 conceived	as	 complex	
in	 relation	 to	 pharmacological	 interventions	




















latter	 for	sex	 (Oliveira;	Bilac;	Muszkat,	2011)	 –	 is	
easily	recognized	in	these	biomedical	perspectives.	
The	complexity	associated	with	 interventions	 in	





of	 the	 woman-reproduction	 versus	man-sex	
associations	goes	beyond	the	biomedical	sciences	
and	their	 technologies	and	can	also	be	 identified	






(Sexuality	was	 for	men	as	 reproduction	was	 for	
women	–	‘natural’).”
We	 can	 thus	 say	 that	 the	 approach	 to	 the	
male	body	became,	at	 least	at	first,	the	model	for	
pharmacological	interventions	in	female	sexuality;	
while	 the	approach	to	 the	 female	body,	primarily	
hormonal,	has	become,	in	the	same	sense,	the	model	
for	contraceptive	 interventions	 in	 the	male	body.	









of	 female	 sexuality	 (Rohden,	 2009),	 and	MCI’s	
criticisms	 of	 the	 hormonal	 paradigm	of	male	
contraception	and	 its	 support	 to	non-hormonal	
approaches	(Pereira,	2017).
The	development	 and	 launching	 of	 a	 “male	
pill,”	 a	 technology	 that	 could	 break	with	 the	
relative	 invisibility	of	 the	 reproductive	body	of	
men,	as	opposed	 to	 the	advancement	of	 the	 (bio)
medicalization	of	their	sexual	body,	has	precisely	
the	 complexity	of	 this	body	as	one	of	 the	main	

















–	 and	 in	 biomedical	 treatments	 –	 increase	 of	














analysis	 of	 how	gender	 conceptions	 permeate	
scientific	descriptions	of	male	and	female	bodies	
and	their	functioning.	In	the	article	“The egg and 
the sperm: how science has constructed a romance 
based on stereotypical male-female roles,”	this	author	
points	out	how	physiological	phenomena	 in	 the	
bodies	of	men	and	women	are	unequally	portrayed,	







to	describe	 the	spermatozoa	 in	 the	 fertilization	
process	are	usually	in	the	active	voice	(“penetrates,”	
“crosses”),	whereas	 in	 the	 case	 of	 ovules,	 they	
appear	 in	 the	passive	voice	 (“is	penetrated,”	 “is	
transported”).	Differences	between	gametes	are	
emphasized,	and	sperm	and	eggs	are	configured	
with	 characteristics	 associated,	 respectively,	










productive	 than	 female	 ones.	 Another	 central	
point	 raised	by	Martin	 is	precisely	 the	 fact	 that	
reproductive	systems,	both	male	and	 female,	are	
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scientists	interpret	their	data	can	have	important	




The	negative	way	 in	which	 the	 female	body	
and	its	functioning	are	interpreted	and	described	
is	emphasized	by	 the	author,	who	questions	 the	


























until	 a	 particular	 enzyme,	 PSA,	 removes	 the	
semenogelin	protein.	After	 the	enzyme	removes	
this	protein,	the	sperm	can	swim	toward	the	egg.16







is	 also	 explicit;	 such	metaphors	are	 constantly	
found	 in	 the	reports	of	MCI	aimed	at	explaining	




Two sexes, two contraceptions
The	analysis	of	 the	physiological	difficulty	 in	
the	MCI	discourse	brings	to	the	fore	the	question	







has	been	questioned	 (Piscitelli,	 2009).	 In	Bodies 
That Matter,	the	philosopher	Judith	Butler	(1993),	


























































































there	are	dissenting	voices	 in	 the	 field	of	male	
contraception	 regarding	 the	 supposed	higher	















and	 conceptions	 of	 organisms	 could	 result	 in	
approaches	and	biomedical	interventions	that	are	
more	symmetrical,	which	would	differ	a	 lot	 from	
current	standards,	 in	which	 the	process	of	 (bio)
medicalization	affect	them	unevenly.	What	is	(bio)
medicalized	in	male	bodies?	And	in	female	bodies?
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Besides	 being	 different,	 such	 bodies	 are	
understood	as	being	more	amenable	to	biomedical	
interventions	in	certain	phenomena,	as	if	a	division	
of	 labor	 or	 a	 propensity	 for	 certain	 activities	
materializes	 in	 the	organisms.	Male	bodies	are	
complex	for	contraceptive	interventions,	but	they	













MCI,	 thus,	 tries	 to	 break	with	gender	 roles	





















































































































Pereira collected data and prepared the first version of the article. 
Pereira and Azize contributed to the data analysis, writing, critical 
review and approval of the final version.
Received: 01/22/2019
Approved: 03/12/2019
